Choreo LLC Purchases New Stake in Doximity, Inc. (NASDAQ:DOCS)

Choreo LLC purchased a new stake in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 4,782 shares of the company's stock, valued at approximately $256,000.

A number of other large investors also recently made changes to their positions in the company. Sanctuary Advisors LLC bought a new stake in Doximity in the second quarter worth about $270,000. Creative Planning raised its position in shares of Doximity by 13.7% in the third quarter. Creative Planning now owns 22,104 shares of the company's stock valued at $963,000 after purchasing an additional 2,671 shares during the period. nVerses Capital LLC raised its position in shares of Doximity by 67.5% in the third quarter. nVerses Capital LLC now owns 12,900 shares of the company's stock valued at $562,000 after purchasing an additional 5,200 shares during the period. Bleakley Financial Group LLC bought a new stake in shares of Doximity in the third quarter valued at approximately $213,000. Finally, Trust Point Inc. raised its position in shares of Doximity by 16.9% in the third quarter. Trust Point Inc. now owns 28,809 shares of the company's stock valued at $1,255,000 after purchasing an additional 4,163 shares during the period. 87.19% of the stock is owned by institutional investors.

Insider Activity

In other news, Director Timothy S. Cabral sold 20,000 shares of the company's stock in a transaction on Monday, February 3rd. The shares were sold at an average price of $57.62, for a total value of $1,152,400.00. Following the completion of the sale, the director now owns 6,360 shares of the company's stock, valued at approximately $366,463.20. This represents a 75.87 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 37.40% of the stock is owned by corporate insiders.

Doximity Stock Up 0.5 %

Shares of Doximity stock traded up $0.42 during trading on Tuesday, reaching $77.49. The company's stock had a trading volume of 987,433 shares, compared to its average volume of 2,343,377. Doximity, Inc. has a 52-week low of $22.96 and a 52-week high of $85.21. The company has a market cap of $14.47 billion, a price-to-earnings ratio of 77.53, a PEG ratio of 4.61 and a beta of 1.39. The firm's 50-day moving average is $58.36 and its two-hundred day moving average is $47.99.

Wall Street Analyst Weigh In

DOCS has been the topic of several research reports. Canaccord Genuity Group lowered shares of Doximity from a "buy" rating to a "hold" rating and boosted their price target for the company from $40.00 to $60.00 in a research report on Wednesday, November 13th. Leerink Partnrs raised shares of Doximity from a "hold" rating to a "strong-buy" rating in a research report on Friday, February 7th. KeyCorp lowered their price target on shares of Doximity from $70.00 to $65.00 and set an "overweight" rating on the stock in a research report on Wednesday, January 8th. Mizuho boosted their price objective on shares of Doximity from $55.00 to $65.00 and gave the company a "neutral" rating in a research note on Monday, February 10th. Finally, Truist Financial boosted their price objective on shares of Doximity from $35.00 to $49.00 and gave the company a "hold" rating in a research note on Thursday, November 14th. Eleven equities research analysts have rated the stock with a hold rating, eight have given a buy rating and two have given a strong buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $64.22.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.